vs
STANDARD BIOTOOLS INC.（LAB）与Waterstone Financial, Inc.（WSBF）财务数据对比。点击上方公司名可切换其他公司
Waterstone Financial, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.9倍（$37.2M vs $19.6M），Waterstone Financial, Inc.同比增速更快（16.7% vs -11.5%），Waterstone Financial, Inc.自由现金流更多（$23.0M vs $-23.1M），过去两年Waterstone Financial, Inc.的营收复合增速更高（7.1% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Waterstone Financial是总部位于美国威斯康星州的银行控股企业，提供零售及商业银行服务、住房抵押贷款、财富管理等多元金融产品，主要服务美国中西部地区的个人消费者与中小微企业，在区域市场拥有稳定的客户基础。
LAB vs WSBF — 直观对比
营收规模更大
WSBF
是对方的1.9倍
$19.6M
营收增速更快
WSBF
高出28.2%
-11.5%
自由现金流更多
WSBF
多$46.1M
$-23.1M
两年增速更快
WSBF
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $37.2M |
| 净利润 | $-34.7M | — |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 27.0% |
| 净利率 | -177.4% | — |
| 营收同比 | -11.5% | 16.7% |
| 净利润同比 | -28.8% | — |
| 每股收益（稀释后） | $-0.09 | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABWSBF
| Q4 25 | — | $37.2M | ||
| Q3 25 | $19.6M | $37.0M | ||
| Q2 25 | $21.8M | $38.0M | ||
| Q1 25 | $40.8M | $29.7M | ||
| Q4 24 | — | $31.8M | ||
| Q3 24 | $22.1M | $34.1M | ||
| Q2 24 | $22.5M | $37.2M | ||
| Q1 24 | $45.5M | $32.4M |
净利润LABWSBF
| Q4 25 | — | — | ||
| Q3 25 | $-34.7M | $7.9M | ||
| Q2 25 | $-33.5M | $7.7M | ||
| Q1 25 | $-26.0M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.9M | $4.7M | ||
| Q2 24 | $-45.7M | $5.7M | ||
| Q1 24 | $-32.2M | $3.0M |
毛利率LABWSBF
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABWSBF
| Q4 25 | — | 27.0% | ||
| Q3 25 | -168.5% | 26.6% | ||
| Q2 25 | -118.1% | 25.4% | ||
| Q1 25 | -80.8% | 13.1% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | -120.9% | 17.3% | ||
| Q2 24 | -134.5% | 19.2% | ||
| Q1 24 | -132.2% | 14.7% |
净利率LABWSBF
| Q4 25 | — | — | ||
| Q3 25 | -177.4% | 21.4% | ||
| Q2 25 | -153.7% | 20.3% | ||
| Q1 25 | -63.8% | 10.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -122.0% | 13.9% | ||
| Q2 24 | -203.3% | 15.4% | ||
| Q1 24 | -70.6% | 9.4% |
每股收益（稀释后）LABWSBF
| Q4 25 | — | $0.43 | ||
| Q3 25 | $-0.09 | $0.45 | ||
| Q2 25 | $-0.09 | $0.43 | ||
| Q1 25 | $-0.07 | $0.17 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | $-0.07 | $0.26 | ||
| Q2 24 | $-0.12 | $0.31 | ||
| Q1 24 | $-0.27 | $0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | $412.3M |
| 股东权益账面价值 | $399.7M | $349.4M |
| 总资产 | $539.6M | $2.3B |
| 负债/权益比越低杠杆越低 | — | 1.18× |
8季度趋势，按日历期对齐
现金及短期投资LABWSBF
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
总债务LABWSBF
| Q4 25 | — | $412.3M | ||
| Q3 25 | — | $469.1M | ||
| Q2 25 | — | $465.7M | ||
| Q1 25 | — | $395.9M | ||
| Q4 24 | — | $446.5M | ||
| Q3 24 | $55.2M | $560.1M | ||
| Q2 24 | $55.1M | $660.8M | ||
| Q1 24 | $55.0M | $634.2M |
股东权益LABWSBF
| Q4 25 | — | $349.4M | ||
| Q3 25 | $399.7M | $345.5M | ||
| Q2 25 | $424.5M | $341.5M | ||
| Q1 25 | $454.6M | $341.4M | ||
| Q4 24 | — | $339.1M | ||
| Q3 24 | $489.3M | $342.0M | ||
| Q2 24 | $510.3M | $334.9M | ||
| Q1 24 | $577.3M | $338.0M |
总资产LABWSBF
| Q4 25 | — | $2.3B | ||
| Q3 25 | $539.6M | $2.3B | ||
| Q2 25 | $557.0M | $2.3B | ||
| Q1 25 | $579.6M | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | $681.5M | $2.2B | ||
| Q2 24 | $708.7M | $2.3B | ||
| Q1 24 | $777.7M | $2.2B |
负债/权益比LABWSBF
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.16× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | 0.11× | 1.64× | ||
| Q2 24 | 0.11× | 1.97× | ||
| Q1 24 | 0.10× | 1.88× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $24.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $23.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 61.9% |
| 资本支出强度资本支出/营收 | 4.5% | 3.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $43.4M |
8季度趋势，按日历期对齐
经营现金流LABWSBF
| Q4 25 | — | $24.2M | ||
| Q3 25 | $-22.2M | $32.7M | ||
| Q2 25 | $-20.7M | $-38.4M | ||
| Q1 25 | $-30.3M | $26.7M | ||
| Q4 24 | — | $48.1M | ||
| Q3 24 | $-27.9M | $74.1M | ||
| Q2 24 | $-39.0M | $-39.5M | ||
| Q1 24 | $-62.5M | $-9.9M |
自由现金流LABWSBF
| Q4 25 | — | $23.0M | ||
| Q3 25 | $-23.1M | $32.4M | ||
| Q2 25 | $-22.6M | $-38.5M | ||
| Q1 25 | $-35.3M | $26.5M | ||
| Q4 24 | — | $47.0M | ||
| Q3 24 | $-30.1M | $73.9M | ||
| Q2 24 | $-41.0M | $-39.7M | ||
| Q1 24 | $-63.3M | $-10.3M |
自由现金流率LABWSBF
| Q4 25 | — | 61.9% | ||
| Q3 25 | -118.1% | 87.5% | ||
| Q2 25 | -103.6% | -101.2% | ||
| Q1 25 | -86.6% | 89.2% | ||
| Q4 24 | — | 147.5% | ||
| Q3 24 | -136.4% | 216.9% | ||
| Q2 24 | -182.2% | -106.7% | ||
| Q1 24 | -138.9% | -31.9% |
资本支出强度LABWSBF
| Q4 25 | — | 3.1% | ||
| Q3 25 | 4.5% | 0.8% | ||
| Q2 25 | 8.7% | 0.2% | ||
| Q1 25 | 12.4% | 0.9% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 10.2% | 0.6% | ||
| Q2 24 | 8.6% | 0.4% | ||
| Q1 24 | 1.7% | 1.2% |
现金转化率LABWSBF
| Q4 25 | — | — | ||
| Q3 25 | — | 4.13× | ||
| Q2 25 | — | -4.98× | ||
| Q1 25 | — | 8.81× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 15.67× | ||
| Q2 24 | — | -6.92× | ||
| Q1 24 | — | -3.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
WSBF
暂无分部数据
